共 10 条
- [4] National Institute for Health and Care Excellence, 2015, Bladder cancer: Diagnosis and management
- [5] Intermediate-risk Non-muscle-invasive Bladder Cancer: Updated Consensus Definition and Management Recommendations from the International Bladder Cancer Group [J]. EUROPEAN UROLOGY ONCOLOGY, 2022, 5 (05): : 505 - 516
- [6] Re: Wei Shen Tan, Aaron Prendergast, Charlotte Ackerman, et al. Adjuvant Intravesical Chemohyperthermia Versus Passive Chemotherapy in Patients with Intermediate-risk Non-muscle-invasive Bladder Cancer (HIVEC-II): A Phase 2, Open-label, Randomised Controlled Trial. Eur Urol. In press. [J]. EUROPEAN UROLOGY, 2023, 83 (02) : E47 - E47